<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04000386</url>
  </required_header>
  <id_info>
    <org_study_id>zincoxide_PK</org_study_id>
    <nct_id>NCT04000386</nct_id>
  </id_info>
  <brief_title>A Study of Efficacy of Zinc Oxide Nanoparticles Coated Socks in Prevention of Unpleasant Foot Odor</brief_title>
  <official_title>A Study of Efficacy of Zinc Oxide Nanoparticles Coated Socks in Prevention of Unpleasant Foot Odor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to study the efficacy of zinc oxide nanoparticles coated socks in prevention
      of unpleasant foot odor
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction Pitted keratolysis is a common skin disease, caused by various gram-positive
      bacteria including Corynebacterium species, Kytococcus sedentarius, Dermatophilus congolensis
      and Actinomyces species. These bacteria create small tunnels in the stratum corneum, causing
      pitted lesions at plantar areas. This condition is frequent accompanied by feet malodor and
      is commonly found in young male adults, especially in soldiers, miners and athletes. The
      reported prevalence of pitted keratolysis among naval cadets in Thailand was 38.7%.
      Predisposing factors related to pitted keratolysis are pedal hyperhidrosis and prolonged feet
      occlusion. Although this condition is generally not painful, our previous study in 2018
      revealed adversely affects patients' quality of life.

      Regarding treatment modalities of pitted keratolysis, various medications and life-style
      modification have been recommended. Previous studies revealed efficacy of topical choices,
      including benzoyl peroxide gel, clindamycin-benzoyl peroxide gel, glycopyrrolate cream,
      erythromycin gel, clindamycin solution, chlorhexidine scrub4 and mupirocin ointment. Oral
      antibiotics and botulinum toxin injection were also beneficial in pitted keratolysis. As to
      life-style modification, wearing cotton socks and opened footwear, and proper hygiene, have
      also been suggested.

      Previous studies demonstrated efficacy of zinc oxide in broad-spectrum antibacterial
      properties. Thus, zinc oxide has been used in various medical and apparel industrial
      products. Moreover, Commander Choopong Chailark invented socks coated with zinc oxide
      nanoparticles and reported antibacterial property of those socks.

      Objective The present study aimed to study the efficacy of zinc oxide nanoparticles coated
      socks in prevention of unpleasant foot odor

      Material and Methods First-year naval rating cadets, who had no pedal malodor were invited to
      enroll in this study. Consent was informed and obtained from all participants. Participants
      were assessed for behavioral risk factors and level of foot odor measured by a self-assessed
      visual analogue scale (VAS), using questionnaires. Subjects were randomly assigned either
      zinc oxide nanoparticles coated socks or ordinary socks.During the study, using of other
      topical treatment such as topical antibiotics, antiperspirant or aluminum chloride was not
      allowed. Participants were advised to wear those socks every day and regularly washed thier
      socks. All were able to regularly participate in physical military training during the study.
      Two weeks after the study clinical examinations by dermatologists and the cadets'
      self-assessment questionnaires, including feet odor by using VAS, treatment satisfaction and
      adverse effects, were used to evaluate the effectiveness. Pitted lesions improvement at
      plantar areas, evaluated by dermatologists, was divided into no improvement, slight
      improvement (decrease of pitted lesions at feet for 1 level) and much improvement (decrease
      of pitted lesions at feet for at least 2 level). Data were analyzed using Predictive
      Analytics SoftWare Statistics version 18 (SPSS, Inc., Chicago, Illinois, USA).

      Duration of study: 4 months

      Study design: Randomized control trial
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 26, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Single (Participant) Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Single blind controlled trial between participants, drug preparing team, doctors, investigators, and outcome assessors.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of zinc oxide nanoparticles coated socks in prevention of unpleasant foot odor</measure>
    <time_frame>2 weeks</time_frame>
    <description>Effectiveness was evaluated by the number of patients who had no or minimal foot odor after prevention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effectiveness of zinc oxide nanoparticles coated socks in prevention of fungal feet infection</measure>
    <time_frame>2 weeks</time_frame>
    <description>Effectiveness was evaluated by the number of patients who had no fungal feet infection after prevention</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Zinc Oxide</condition>
  <condition>Foot Dermatoses</condition>
  <arm_group>
    <arm_group_label>zinc oxide nanoparticles coated socks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>62 patients with zinc oxide nanoparticles coated socks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>62 patients with placebo socks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>zinc oxide nanoparticles coated socks</intervention_name>
    <description>zinc oxide nanoparticles coated socks were given to subjects for 2 weeks</description>
    <arm_group_label>zinc oxide nanoparticles coated socks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo socks</intervention_name>
    <description>placebo socks were given to subjects for 2 weeks</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  First-year naval rating cadets, who had no pedal malodor

        Exclusion Criteria:

          -  The cadets who previously received any topical treatment including topical antibiotic,
             antiperspirant or aluminum chloride within 6 months prior to the study.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Charussri Leeyaphan, MD</last_name>
    <phone>+664194333</phone>
    <email>charussrilee@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sumanas Bunyaratavej, MD</last_name>
    <phone>+664194333</phone>
    <email>consultskin@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Dermatology Siriraj Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sumanas Bunyaratavej, MD</last_name>
      <phone>: +664194333</phone>
      <email>consultskin@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Charussri Leeyaphan,, MD</last_name>
      <phone>: +664194333</phone>
      <email>charussrilee@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Sumanas Bunyaratavej, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charassri Leeyaphan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <results_reference>
    <citation>de Almeida HL Jr, Siqueira RN, Meireles Rda S, Rampon G, de Castro LA, Silva RM. Pitted keratolysis. An Bras Dermatol. 2016 Jan-Feb;91(1):106-8. doi: 10.1590/abd1806-4841.20164096.</citation>
    <PMID>26982791</PMID>
  </results_reference>
  <results_reference>
    <citation>Makhecha M, Dass S, Singh T, Gandhi R, Yadav T, Rathod D. Pitted keratolysis - a study of various clinical manifestations. Int J Dermatol. 2017 Nov;56(11):1154-1160. doi: 10.1111/ijd.13744. Epub 2017 Sep 18.</citation>
    <PMID>28924971</PMID>
  </results_reference>
  <results_reference>
    <citation>van der Snoek EM, Ekkelenkamp MB, Suykerbuyk JC. Pitted keratolysis; physicians' treatment and their perceptions in Dutch army personnel. J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1120-6. doi: 10.1111/j.1468-3083.2012.04674.x. Epub 2012 Aug 7.</citation>
    <PMID>22882561</PMID>
  </results_reference>
  <results_reference>
    <citation>Leeyaphan C, Bunyaratavej S, Taychakhoonavudh S, Kulthanachairojana N, Pattanaprichakul P, Chanyachailert P, Ongsri P, Arunkajohnsak S, Limphoka P, Kulthanan K. Cost-effectiveness analysis and safety of erythromycin 4% gel and 4% chlorhexidine scrub for pitted keratolysis treatment. J Dermatolog Treat. 2019 Sep;30(6):627-629. doi: 10.1080/09546634.2018.1543846. Epub 2018 Dec 11.</citation>
    <PMID>30415588</PMID>
  </results_reference>
  <results_reference>
    <citation>Vlahovic TC, Dunn SP, Kemp K. The use of a clindamycin 1%-benzoyl peroxide 5% topical gel in the treatment of pitted keratolysis: a novel therapy. Adv Skin Wound Care. 2009 Dec;22(12):564-6. doi: 10.1097/01.ASW.0000363468.18117.fe.</citation>
    <PMID>19935134</PMID>
  </results_reference>
  <results_reference>
    <citation>Bunyaratavej S, Leeyaphan C, Chanyachailert P, Pattanaprichakul P, Ongsri P, Kulthanan K. Clinical manifestations, risk factors and quality of life in patients with pitted keratolysis: a cross-sectional study in cadets. Br J Dermatol. 2018 Nov;179(5):1220-1221. doi: 10.1111/bjd.16923. Epub 2018 Sep 14.</citation>
    <PMID>29951993</PMID>
  </results_reference>
  <results_reference>
    <citation>Burkhart CG. Pitted keratolysis: a new form of treatment. Arch Dermatol. 1980 Oct;116(10):1104.</citation>
    <PMID>7425659</PMID>
  </results_reference>
  <results_reference>
    <citation>Balić A, Bukvić Mokos Z, Marinović B, Ledić Drvar D. Tatami Mats: A Source of Pitted Keratolysis in a Martial Arts Athlete? Acta Dermatovenerol Croat. 2018 Apr;26(1):68-70. Review.</citation>
    <PMID>29782305</PMID>
  </results_reference>
  <results_reference>
    <citation>Kontochristopoulos G, Sidiropoulou P, Tzanetakou V, Markantoni V, Platsidaki E, Agiasofitou E, Rigopoulos D, Gregoriou S. Managing pitted keratolysis: consider topical glycopyrrolate. Clin Exp Dermatol. 2019 Aug;44(6):713-714. doi: 10.1111/ced.13851. Epub 2018 Dec 4.</citation>
    <PMID>30515854</PMID>
  </results_reference>
  <results_reference>
    <citation>Pranteda G, Carlesimo M, Pranteda G, Abruzzese C, Grimaldi M, De Micco S, Muscianese M, Bottoni U. Pitted keratolysis, erythromycin, and hyperhidrosis. Dermatol Ther. 2014 Mar-Apr;27(2):101-4. doi: 10.1111/dth.12064. Epub 2013 May 24.</citation>
    <PMID>24703267</PMID>
  </results_reference>
  <results_reference>
    <citation>Greywal T, Cohen PR. Pitted keratolysis: successful management with mupirocin 2% ointment monotherapy. Dermatol Online J. 2015 Aug 15;21(8). pii: 13030/qt6155v9wk. Review.</citation>
    <PMID>26437161</PMID>
  </results_reference>
  <results_reference>
    <citation>Vazquez-Lopez F, Perez-Oliva N. Mupirocine ointment for symptomatic pitted keratolysis. Infection. 1996 Jan-Feb;24(1):55.</citation>
    <PMID>8852468</PMID>
  </results_reference>
  <results_reference>
    <citation>Tamura BM, Cucé LC, Souza RL, Levites J. Plantar hyperhidrosis and pitted keratolysis treated with botulinum toxin injection. Dermatol Surg. 2004 Dec;30(12 Pt 2):1510-4.</citation>
    <PMID>15606827</PMID>
  </results_reference>
  <results_reference>
    <citation>Fiedot-Toboła M, Ciesielska M, Maliszewska I, Rac-Rumijowska O, Suchorska-Woźniak P, Teterycz H, Bryjak M. Deposition of Zinc Oxide on Different Polymer Textiles and Their Antibacterial Properties. Materials (Basel). 2018 Apr 30;11(5). pii: E707. doi: 10.3390/ma11050707.</citation>
    <PMID>29710873</PMID>
  </results_reference>
  <results_reference>
    <citation>Raghunath A, Perumal E. Metal oxide nanoparticles as antimicrobial agents: a promise for the future. Int J Antimicrob Agents. 2017 Feb;49(2):137-152. doi: 10.1016/j.ijantimicag.2016.11.011. Epub 2017 Jan 3. Review.</citation>
    <PMID>28089172</PMID>
  </results_reference>
  <results_reference>
    <citation>Dizaj SM, Lotfipour F, Barzegar-Jalali M, Zarrintan MH, Adibkia K. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:278-84. doi: 10.1016/j.msec.2014.08.031. Epub 2014 Aug 16. Review.</citation>
    <PMID>25280707</PMID>
  </results_reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 26, 2019</study_first_submitted>
  <study_first_submitted_qc>June 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2019</study_first_posted>
  <last_update_submitted>June 26, 2019</last_update_submitted>
  <last_update_submitted_qc>June 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pitted keratolysis</keyword>
  <keyword>zinc oxide</keyword>
  <keyword>Foot Odor</keyword>
  <keyword>preventsion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
    <mesh_term>Foot Dermatoses</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zinc Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

